Winrevair Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage Patient Counseling Information MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

Powder: white to off-white powder.
Solvent: clear colourless water for injections.
Winrevair powder and solvent for solution for injection 45 mg: Each vial contains 45 mg of sotatercept. After reconstitution, each mL of solution contains 50 mg sotatercept.
Winrevair powder and solvent for solution for injection 60 mg: Each vial contains 60 mg of sotatercept. After reconstitution, each mL of solution contains 50 mg sotatercept.
Sotatercept is a recombinant homodimeric fusion protein consisting of the extracellular domain of human activin receptor type IIA (ActRIIA) linked to the Fc domain of human IgG1, produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology.
Excipients/Inactive Ingredients: Powder: Citric acid monohydrate (E330), Sodium citrate (E331), Polysorbate 80 (E433), Sucrose.
Solvent: Water for injections.

Manufacturer:

MSD

Distributor:

Zuellig

Agencia Lei Va Hong